Biopharmaceutical Market (By Product: Monoclonal antibody, Interferon, Insulin, Growth and coagulation factor, Erythropoietin, Vaccine, Hormone, Others; By Application: Oncology, Blood disorder, Metabolic disease, Infectious disease, Cardiovascular disease, Neurological disease, Immunology, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast 2020 - 2027

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

CHAPTER 1. Industry Overview of Biopharmaceutical
1.1. Definition and Scope 
1.1.1. Definition of Biopharmaceutical
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Biopharmaceutical Market
1.2. Summary
1.2.1. Executive Summary 
1.2.2. Biopharmaceutical Market By Product
1.2.3. Biopharmaceutical Market By Application
1.2.4. Biopharmaceutical Market by Regions

CHAPTER 2. Research Approach
2.1. Methodology 
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2 
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Biopharmaceutical Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Biopharmaceutical Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers 
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019
4.2. R&D Status and Application Source of Biopharmaceutical Major Manufacturers in 2019

CHAPTER 5. Biopharmaceutical Market By Product
5.1. Introduction
5.2. Biopharmaceutical Revenue By Product
5.2.1. Biopharmaceutical Revenue (US$ Mn) and Forecast, By Product, 2016-2027
5.2.2. Monoclonal antibody
5.2.2.1. Monoclonal antibody Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Interferon
5.2.3.1. Interferon Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Insulin
5.2.4.1. Insulin Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Growth and coagulation factor
5.2.5.1. Growth and coagulation factor  Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.6. Erythropoietin
5.2.6.1. Erythropoietin  Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.7. Vaccine
5.2.7.1. Vaccine Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.8. Hormone
5.2.8.1. Hormone Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.9. Others
5.2.9.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 6. Biopharmaceutical Market Revenue By Application
6.1. Introduction
6.2. Biopharmaceutical Revenue (US$ Mn) By Application
6.2.1. Biopharmaceutical Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
6.2.2. Oncology
6.2.2.1. Oncology Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Blood disorder
6.2.3.1. Blood disorder Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Metabolic disease
6.2.4.1. Metabolic disease Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.5. Infectious disease
6.2.5.1. Infectious disease Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.6. Cardiovascular disease
6.2.6.1. Cardiovascular disease Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.7. Neurological disease
6.2.7.1. Neurological disease Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.8. Immunology
6.2.8.1. Immunology Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.9. Others
6.2.9.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 7. North America Biopharmaceutical Market By Country 
7.1. North America Biopharmaceutical Overview
7.2. U.S.
7.2.1. U.S. Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
7.2.2. U.S. Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.3. Canada
7.3.1. Canada Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
7.3.2. Canada Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.4. North America PEST Analysis

CHAPTER 8. Europe Biopharmaceutical Market By Country
8.1. Europe Biopharmaceutical Market Overview
8.2. U.K.
8.2.1. U.K. Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.2.2. U.K. Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.3. Germany
8.3.1. Germany Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.3.2. Germany Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.4. France 
8.4.1. France Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.4.2. France Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.5. Spain
8.5.1. Spain Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.5.2. Spain Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.6. Rest of Europe
8.6.1. Rest of Europe Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.6.2. Rest of Europe Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.7. Europe PEST Analysis

CHAPTER 9. Asia Pacific Biopharmaceutical Market By Country
9.1. Asia Pacific Biopharmaceutical Market Overview
9.2. China
9.2.1. China Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.2.2. China Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.3. Japan
9.3.1. Japan Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.3.2. Japan Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.4. India
9.4.1. India Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.4.2. India Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.5. Australia
9.5.1. Australia Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.5.2. Australia Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.6. South Korea
9.6.1. South Korea Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.6.2. South Korea Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
9.7.2. Rest of Asia-Pacific Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.8. Asia Pacific PEST Analysis

CHAPTER 10. Latin America Biopharmaceutical Market By Country
10.1. Latin America Biopharmaceutical Market Overview
10.2. Brazil
10.2.1. Brazil Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.2.2. Brazil Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.3. Mexico
10.3.1. Mexico Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
10.3.2. Mexico Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.4. Rest of Latin America
10.4.1. Rest of Latin America Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Product, 2016 – 2027
10.4.2. Rest of Latin America Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

CHAPTER 11. Middle East & Africa Biopharmaceutical Market By Country 
11.1. Middle East & Africa Biopharmaceutical Market Overview
11.2. Saudi Arabia
11.2.1. Saudi Arabia Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.2.2. Saudi Arabia Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.3. UAE
11.3.1. UAE Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.3.2. UAE Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Product, 2016 - 2027
11.4.2. Rest of Middle East & Africa Biopharmaceutical Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027

CHAPTER 12. Player Analysis Of Biopharmaceutical
12.1. Biopharmaceutical Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Biopharmaceutical Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 13. COMPANY PROFILE
13.1. Abbott
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (US$ Mn), 2019
13.1.3.2. Abbott 2019 Biopharmaceutical Business Regional Distribution
13.1.4. Product/ Service and Specification
13.1.5. Recent Developments & Business Strategy
13.1.6. Manufacturing Plant Footprint Analysis
13.2. Amgen Inc.
13.3. Biogen Inc.
13.4. Eli Lilly and Company
13.5. F. Hoffmann-La Roche AG
13.6. Johnson & Johnson Services, Inc. 
13.7. Merck Sharp & Dohme Corp. 
13.8. Novo Nordisk A/S
13.9. Pfizer Inc.
13.10. Sanofi
13.11. Others

Cart Summary